Dynamic Technology Lab Private LTD Horizon Therapeutics Public LTD CO Transaction History

Dynamic Technology Lab Private LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $9.83 Million - $11.5 Million	99,280 Added 3203.61%	102,379 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $298,557 - $348,265	3,099 New	3,099 $319,000
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $1.85 Million - $2.71 Million	23,330 New	23,330 $1.86 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $308,519 - $392,021	-3,570 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $62,782 - $76,382	637 Added 21.72%	3,570 $385,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $269,572 - $323,715	2,933 New	2,933 $321,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $188,520 - $209,681	-2,186 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $157,020 - $208,719	2,186 New	2,186 $201,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $205,623 - $258,992	-3,069 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $169,500 - $245,305	3,069 New	3,069 $238,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $335,087 - $407,494	-14,569 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $332,318 - $414,925	14,569 New	14,569 $351,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.